So far, we treat patients homogeneously, and we need to move to more personalized immunotherapy. There is a lot of ongoing research to understand what is special about patients who respond ...

Allergy immunotherapy ... by using a testing kit shipped to their home for the collection of a small blood sample. Once the lab concludes the test, patients will receive personalized treatment ...

One type of immunotherapy known as adoptive cell transfer (ACT ... regimen's safety by showing that cancer patients can tolerate ACT with T cells modified to express personalized neoantigen-reactive ...

In a step likely to advance personalized cancer treatment ... not enough to tell which patients are likely to respond best to immunotherapy. Instead, clinicians need to understand how immune ...

The next time oncologists ask for regular blood testing, they can order the Signatera kit as well. Natera then uses that personalized test to look for evidence of that cancer's circulating tumor DNA.

Adding a personalized anti-tumor vaccine to standard immunotherapy is safe and about twice as likely to shrink cancer as standard immunotherapy alone for patients with hepatocellular carcinoma ...

During the webinar, you’ll learn how doggybone DNA is being used to support the development of a personalized cancer immunotherapy treatment developed by Odimma Therapeutics, and how it helps ...

STRASBOURG, France--(BUSINESS WIRE)--Odimma Therapeutics, a biotechnology company specialized in personalized cancer immunotherapy announces a seed fundraising of €2 million in order to secure the ...

The personalized immunotherapy shrank tumors in some patients and was able to keep the tumors from regrowing for up to seven months. The findings were published July 11, 2024, in Nature Medicine.